Chapter 8. Hormones and Sex
Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.
THAT health and beauty are linked is not in doubt. But it comes as something of a surprise that who is perceived as beautiful depends not only on the health of the person in question but also on the average level of health in the place where she lives. This, though, is the conclusion of a study just published in Biology Letters by Urszula Marcinkowska of the University of Turku, in Finland, and her colleagues—for Ms Marcinkowska has found that men in healthy countries think women with the most feminine faces are the prettiest whilst those in unhealthy places prefer more masculine-looking ones. Ms Marcinkowska came to this conclusion by showing nearly 2,000 men from 28 countries various versions of the same female faces, modified to look less or more feminine, and thus reflect the effects of different levels of oestrogen and testosterone. Oestrogen promotes features, such as large eyes and full lips, that are characteristically feminine. Testosterone promotes masculine features, such as wide faces and strong chins. As the chart shows, the correlation is remarkable—and statistical analysis shows it is unconnected with a country’s wealth or its ratio of men to women and thus the amount of choice available to men. The cause, though, is unclear. Previous studies have shown that women with feminine features are more fertile. A man’s preference for them is thus likely to enhance his reproductive success. Ms Marcinkowska speculates that testosterone-induced behavioural characteristics like dominance, which might be expected to correlate with masculine-looking faces even in women (they certainly do in men), help in the competition for resources needed to sustain children once they are born. But why that should be particularly important in an unhealthy country is unclear.
Combining the estrogen hormone estriol with Copaxone, a drug indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS), may improve symptoms in patients with the disorder, according to preliminary results from a clinical study of 158 patients with relapsing remitting multiple sclerosis (RRMS). The findings were presented today by Rhonda Voskuhl, M.D., from the University of California, Los Angeles, at the American Academy of Neurology Annual Meeting in Philadelphia. The study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health; and the National Multiple Sclerosis Society. “While these results are encouraging, the results of this Phase II study should be considered preliminary as a larger study would be needed to know whether benefits outweigh the risks for persons affected by MS. At present, we cannot recommend estrogen as part of standard therapy for MS. We encourage patients to talk with their doctors before making any changes to their treatment plans,” said Walter Koroshetz, M.D., deputy director of NINDS. MS is an autoimmune disorder in which immune cells break down myelin, a protective covering that wraps around nerve cells. Loss of myelin results in pain, movement and balance problems as well as changes in cognitive ability. RRMS is the most common form of the disorder. Patients with RRMS experience relapses, or flare-ups, of neurological symptoms, followed by recovery periods during which the symptoms improve.
Jeffrey Mogil’s students suspected there was something fishy going on with their experiments. They were injecting an irritant into the feet of mice to test their pain response, but the rodents didn’t seem to feel anything. “We thought there was something wrong with the injection,” says Mogil, a neuroscientist at McGill University in Montreal, Canada. The real culprit was far more surprising: The mice that didn’t feel pain had been handled by male students. Mogil’s group discovered that this gender distinction alone was enough to throw off their whole experiment—and likely influences the work of other researchers as well. “This is very important work with wide-ranging implications,” says M. Catherine Bushnell, a neuroscientist and the scientific director of the Division of Intramural Research at the National Center for Complementary and Alternative Medicine (NCCAM) in Bethesda, Maryland, who was not involved in the study. “Many people doing research have never thought of this.” Mogil has studied pain for 25 years. He’s long suspected that lab animals respond differently to the sensation when researchers are present. In 2007, his lab observed that mice spend less time licking a painful injection—a sign that they’re hurting—when a person is nearby, even if that “person” is a cardboard cutout of Paris Hilton. Other scientists began to wonder if their own data were biased by the same effect. “There were whisperings at meetings that this was confounding research results,” Mogil says. So he decided to take a closer look. In the new study, Mogil told the researchers in his lab to inject an inflammatory agent into the foot of a rat or mouse and then take a seat nearby and read a book. A video camera trained on the rodent’s face assessed the animal’s pain level, based on a 0- to 2-point “grimace scale” developed by the team. The results were mixed. Sometimes the animals showed pain when an experimenter was present, and sometimes they seemed just fine. So, on a hunch, Mogil and colleagues recrunched the data, this time controlling for whether a male or a female experimenter was present. “We were stunned by the results,” he says. © 2014 American Association for the Advancement of Science.
The hormone oxytocin appears to increase social behaviors in newborn rhesus monkeys, according to a study by researchers at the National Institutes of Health, the University of Parma in Italy, and the University of Massachusetts, Amherst. The findings indicate that oxytocin is a promising candidate for new treatments for developmental disorders affecting social skills and bonding. Oxytocin, a hormone produced by the pituitary gland, is involved in labor and birth and in the production of breast milk. Studies have shown that oxytocin also plays a role in parental bonding, mating, and in social dynamics. Because of its possible involvement in social encounters, many researchers have suggested that oxytocin might be useful as a treatment for conditions affecting social behaviors, such as autism spectrum disorders. Although oxytocin has been shown to increase certain social behaviors in adults, before the current study it had not been shown to do so in primate infants of any species. Working with infant rhesus monkeys, the NIH researchers found that oxytocin increased two facial gestures associated with social interactions— one used by the monkeys themselves in certain social situations, the other in imitation of their human caregivers. “It was important to test whether oxytocin would promote social behaviors in infants in the same respects as it appears to promote social interaction among adults,” said the study’s first author, Elizabeth A. Simpson, Ph.D., postdoctoral fellow of the University of Parma, conducting research in the Comparative Behavioral Genetics Section of the NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development. “Our results indicate that oxytocin is a candidate for further studies on treating developmental disorders of social functioning.” The study was published online in Proceedings of the National Academy of Sciences.
Epigenetics is one of the hottest fields in the life sciences. It’s a phenomenon with wide-ranging, powerful effects on many aspects of biology, and enormous potential in human medicine. As such, its ability to fill in some of the gaps in our scientific knowledge is mentioned everywhere from academic journals to the mainstream media to some of the less scientifically rigorous corners of the Internet. Epigenetics is essentially additional information layered on top of the sequence of letters (strings of molecules called A, C, G, and T) that makes up DNA. If you consider a DNA sequence as the text of an instruction manual that explains how to make a human body, epigenetics is as if someone's taken a pack of highlighters and used different colours to mark up different parts of the text in different ways. For example, someone might use a pink highlighter to mark parts of the text that need to be read the most carefully, and a blue highlighter to mark parts that aren't as important. There are different types of epigenetic marks, and each one tells the proteins in the cell to process those parts of the DNA in certain ways. For example, DNA can be tagged with tiny molecules called methyl groups that stick to some of its C letters. Other tags can be added to proteins called histones that are closely associated with DNA. There are proteins that specifically seek out and bind to these methylated areas, and shut it down so that the genes in that region are inactivated in that cell. So methylation is like a blue highlighter telling the cell "you don't need to know about this section right now." Methyl groups and other small molecular tags can attach to different locations on the histone proteins, each one having a different effect. Some tags in some locations loosen the attachment between the DNA and the histone, making the DNA more accessible to the proteins that are responsible for activating the genes in that region; this is like a pink highlighter telling the cell "hey, this part's important". © 2014 Guardian News and Media Limited
by Laura Sanders When a baby cries at night, exhausted parents scramble to figure out why. He’s hungry. Wet. Cold. Lonely. But now, a Harvard scientist offers more sinister explanation: The baby who demands to be breastfed in the middle of the night is preventing his mom from getting pregnant again. This devious intention makes perfect sense, says evolutionary biologist David Haig, who describes his idea in Evolution, Medicine and Public Health. Another baby means having to share mom and dad, so babies are programmed to do all they can to thwart the meeting of sperm and egg, the theory goes. Since babies can’t force birth control pills on their mothers, they work with what they’ve got: Nighttime nursing liaisons keep women from other sorts of liaisons that might lead to another child. And beyond libido-killing interruptions and extreme fatigue, frequent night nursing also delays fertility in nursing women. Infant suckling can lead to hormone changes that put the kibosh on ovulation (though not reliably enough to be a fail-safe birth control method, as many gynecologists caution). Of course, babies don’t have the wherewithal to be interrupting their mothers’ fertility intentionally. It’s just that in our past, babies who cried to be nursed at night had a survival edge, Haig proposes. The timing of night crying seems particularly damning, Haig says. Breastfed babies seem to ramp up their nighttime demands around 6 months of age and then slowly improve — precisely the time when a baby would want to double down on its birth control efforts. © Society for Science & the Public 2000 - 2013
Here to stay. The Y chromosome is small compared with the X, but is required to keep levels of some genes high enough for mammals to survive. The small, stumpy Y chromosome—possessed by male mammals but not females, and often shrugged off as doing little more than determining the sex of a developing fetus—may impact human biology in a big way. Two independent studies have concluded that the sex chromosome, which shrank millions of years ago, retains the handful of genes that it does not by chance, but because they are key to our survival. The findings may also explain differences in disease susceptibility between men and women. “The old textbook description says that once maleness is determined by a few Y chromosome genes and you have gonads, all other sex differences stem from there,” says geneticist Andrew Clark of Cornell University, who was not involved in either study. “These papers open up the door to a much richer and more complex way to think about the Y chromosome.” The sex chromosomes of mammals have evolved over millions of years, originating from two identical chromosomes. Now, males possess one X and one Y chromosome and females have two Xs. The presence or absence of the Y chromosome is what determines sex—the Y chromosome contains several genes key to testes formation. But while the X chromosome has remained large throughout evolution, with about 2000 genes, the Y chromosome lost most of its genetic material early in its evolution; it now retains less than 100 of those original genes. That’s led some scientists to hypothesize that the chromosome is largely indispensable and could shrink away entirely. © 2014 American Association for the Advancement of Science.
Keyword: Sexual Behavior
Link ID: 19531 - Posted: 04.24.2014
It takes a lot to deter a male from wanting sex. A new study has found that male mice keep trying to copulate even when they are in pain, whereas females engage in less sex. But when given drugs that target pleasure centers in the human brain, the females again became interested. The findings could shed light on the nature of libido across various animal species. To assess how pain influences sexual desire, researchers first identified pairs of mice that wanted to have sex. “What we found early on was not all mice will mate with each other,” says clinical psychologist Melissa Farmer, who led the study while earning her Ph.D. at McGill University in Montreal, Canada. The team set up the rodents on a series of “dates,” during which a male and female were paired together for 30 minutes. Couples that copulated for most of the session were deemed compatible and moved into a cage with separate rooms. A small doorway allowed a female mouse to freely cross over from her chamber, but the male—which is larger—could not. The scientists then induced pain in males or females by applying a small dose of inflammatory compounds to the cheek, tail, foot, or genitals. The sensation would primarily be soreness, like a bad sunburn, says Farmer, who now works at Northwestern University’s Feinberg School of Medicine in Chicago, Illinois. Female mice that were in pain, whether genital or nongenital, spent 50% less time with their male partners, implying a decrease in sexual motivation. Even when they did visit their paramours, females wouldn’t allow males to mount them with the same frequency, the team reports online today in The Journal of Neuroscience. © 2014 American Association for the Advancement of Science.
|By Daisy Yuhas Strange as it may sound, some scientists suspect that the humble armpit could be sending all kinds of signals from casual flirtation to sounding the alarm. That’s because the body’s secretions, some stinky and others below the threshold your nose can detect, may be rife with chemical messages called pheromones. Yet despite half a century of research into these subtle cues, we have yet to find direct evidence of their existence in humans. Humans and other animals have an olfactory system designed to detect and discriminate between thousands of chemical compounds. For more than 50 years, scientists have been aware of the fact that certain insects and animals can release chemical compounds—often as oils or sweat—and that other creatures can detect and respond to these compounds, which allows for a form of silent, purely chemical communication. Although the exact definition has been debated and redefined several times, pheromones are generally recognized as single or small sets of compounds that transmit signals between organisms of the same species. They are typically just one part of the larger potpourri of odorants emitted from an insect or animal, and some pheromones do not have a discernable scent. Since pheromones were first defined in 1959, scientists have found many examples of pheromonal communication. The most striking of these signals elicits an immediate behavioral response. For example, the female silk moth releases a trail of the molecule bombykol, which unerringly draws males from the moment they encounter it. Slower-acting pheromones can affect the recipient’s reproductive physiology, as when the alpha-farnesene molecule in male mouse urine accelerates puberty in young female mice. © 2014 Scientific American
by Bethany Brookshire Every hipster knows that something is only cool before it becomes popular. There’s no point in liking a band once it hits the big time. That shirt is no good once it’s no longer ironic. And it’s certainly not enough to go clean shaven or grow a short beard — that’s much too mainstream. Recent years have seen a resurgence of moustaches, mutton chops and Fu Manchus. A style that really stands out sticks it to conformity. It turns out that when people buck the facial hair trend, they may end up making themselves more attractive. A new study published April 16 in Biology Letters shows that either clean-shaven or fully bearded looks become more attractive when they are rare in the population. The study suggests that humans may practice what’s called negative frequency-dependent selection — people rate rare looks as more attractive than they might otherwise. But when we try to figure out why, the interpretations can get pretty hairy. In every population, there is variation, both in genetics and in how individuals look. But at first blush, this variation doesn’t make a lot of sense. If one particular look is the most attractive and best for the population, sexual selection should make a species converge on a single, popular look. For example, if the best male guppies have stripes, soon all male guppies will have stripes, as females will only mate with stripey males. But in nature, this is clearly not the case. Guppies come in a wild variety of patterns, and so do humans. In guppies, this variation is a result of negative frequency-dependent selection: Female guppies prefer male guppies that look unusual compared to others, rather than guppies that share common features. This helps keep looks and genes variable, a distinct advantage for the species. So an individual guppy’s attractiveness doesn’t just depend on his shining character, it depends on how rare his looks are in relation to other guppies. © Society for Science & the Public 2000 - 2013
Scientists haven’t pinpointed a definitive cause for Alzheimer’s disease—a fatal brain disorder that robs people of their memory and cognitive abilities. But now researchers have uncovered an intriguing clue about why more women than men develop the condition. A particular gene variant, found in a quarter of the population and long known to raise people’s risk for the disease, seems less menacing in men, new research shows. The findings could have implications for potential gender-specific treatments, some Alzheimer’s investigators suggest. Though a small percentage of Alzheimer’s cases arise from genetic mutations that cause obvious disease before the age of 65, the vast majority of people who develop the condition do so later in life from undefined triggers, some thought to be genetic. In 1993, scientists found that people who inherit a gene variant called apolipoprotein E4 (APOE4) are more prone to the common form of Alzheimer’s that strikes in late life. There’s also a “risk-neutral” variant (APOE3) and a much rarer version of the gene (APOE2) that decreases a person’s risk for Alzheimer’s. Shortly thereafter, other research groups replicated the finding and some data hinted that APOE4 raises Alzheimer’s risk more in women than in men. Indeed, when scientists combed through a massive data set containing 5930 Alzheimer’s patients and 8607 dementia-free elderly from 40 independent studies, they reported in 1997 that females with the APOE4 variant were four times more likely to have Alzheimer’s compared with people with the more common, neutral form of the gene. However, in men, APOE4 seemed virtually harmless. “It was a pretty big effect,” says Michael Greicius, a neurologist at Stanford University Medical Center in California, of the analysis. Yet the findings didn’t create much of a stir at the time. © 2014 American Association for the Advancement of Science
by Agata Blaszczak-Boxe, LiveScience.com Unlike many humans, some monkeys are genuinely faithful to their mates. A species known as Azara's owl monkeys tends to be monogamous, according to a new study of these primates. The research also found that the monkeys' inclination to be faithful was related to the male monkeys' tendency to care for their offspring. "They [Azara's owl monkeys] live in pairs, so, in a group, we have only one adult male and one adult female, and both of them are faithful," study author Maren Huck, a professor at the University of Derby in England, told Live Science. "We found a link between... parental care and having few instances of cheating," Huck said. Researchers had known before this study that members of the Azara's species were socially monogamous, which means that males and females live in pairs. But in animals, including humans, social monogamy is not always equivalent to what researchers call genetic monogamy, where females and males only reproduce with their mates. One way researchers can check for genetic monogamy is to analyze the DNA of mating pairs, and check the paternity of the offspring. In the study, the researchers analyzed field observations of the monkeys' behavior, along with genetic samples from a total of 128 monkeys, including some that lived in groups, and others that were solitary "floaters." The material used by the research team included samples from 35 offspring that were born to 17 reproducing pairs. © 2014 Discovery Communications, LLC
By KATRINA KARKAZIS and REBECCA JORDAN-YOUNG In 2009, the South African middle-distance runner Caster Semenya was barred from competition and obliged to undergo intrusive and humiliating “sex testing” after fellow athletes at the Berlin World Championships questioned her sex. Ms. Semenya was eventually allowed to compete again, but the incident opened the world’s eyes to the process of sex testing and the distress it could bring to an athlete who had lived her whole life as a girl. When an endocrinologist, a gynecologist and a psychologist were brought in to determine whether the teenager was really a woman, she simply asserted, “I know who I am.” From 2011, major sports governing bodies, including the International Olympic Committee, the Fédération Internationale de Football Association and the International Association of Athletics Federations, instituted new eligibility rules that were intended to quell the outrage over the handling of the Semenya case. Instead, as recent cases attest, they may have made things worse. Rather than trying to decide whether an athlete is “really” female, as decades of mandatory sex tests did, the current policy targets women whose bodies produce more testosterone than is typical. If a female athlete’s T level is deemed too high, a medical team selected by the sport’s governing bodies develops a “therapeutic proposal.” This involves either surgery or drugs to lower the hormone level. If doctors can lower the athlete’s testosterone to what the governing bodies consider an appropriate level, she may return to competition. If she refuses to cooperate with the investigation or the medical procedures, she is placed under a permanent ban from elite women’s sports. © 2014 The New York Times Company
By Helen Briggs BBC News Young men with an eating disorder are not getting the help and support they need because of a perceptions about a "women's illness", say researchers. Men are underdiagnosed and undertreated for anorexia and other eating disorders, despite making up about a quarter of cases, a UK study suggests. Frontline health workers have a key role in identifying eating disorders in young men, they report in BMJ Open. Men are under pressure to have the "ideal" body image, says a charity. Researchers from the University of Oxford and University of Glasgow interviewed 39 young people aged 16 to 25, including 10 men, about their experiences of diagnosis, treatment and support for eating disorders. They say young men with eating disorders were "underdiagnosed, undertreated and underresearched". This is partly because the men themselves were unaware of the symptoms, despite purging, not eating for days or obsessive calorie counting, they said. "Our findings suggest that men may experience particular problems in recognising that they may have an eating disorder as a result of the continuing cultural construction of eating disorders as uniquely or predominantly a female problem," said Dr Ulla Raisanen and Dr Kate Hunt. One man said he thought eating disorders only affected "fragile teenage girls"; another said he thought eating disorders were "something girls got"; while one was told by his doctor to "man up". Others said they often had to wait a long time for specialist referral and had sometimes been misdiagnosed. GPs and other professionals such as teachers have a key role in improving the outlook for men with eating disorders by challenging misconceptions, the researchers said. BBC © 2014
Julia Baird SYDNEY, Australia — PRETTY much the No. 1 question you are asked when you’re pregnant is: “Girl or boy?” If you choose not to find out, but to be deliciously surprised at birth, as I did, then you will be asked to guess: “What do you feel it is?” I used to scrunch up my eyes and try hard to draw on what people told me was an age-old female intuition: Which genitals were sprouting in my round belly? I could never tell, though. It is as though the entire world is trying to guess what, or who, is inside you. One oft-told tale is that girls steal your looks and make you fat, while boys just make your belly stick out straight. When I stood wearily bulging at one friend’s baby shower in Manhattan, a stylist confided that she thought our mutual friend was having a boy, because she looked so pretty. Then she looked me up and down: “I think you’re having a girl.” (I placed her in the same category as the neighbor who yelled, “Morning, Fatty!” over the side fence each day.) Why is whether a baby wears blue or pink the most pressing matter for adult acquaintances of a soon-to-be-born? Green is just fine, or white. But a 2007 Gallup poll found that most young Americans, and women under 50, would like to find out the sex of their baby before it is born. In some American fertility clinics, staff experts check the embryo’s sex before they implant it in the womb. So what will it do to our collective minds when forced to grasp that some people are neither gender? Not male, or female, but something else either encompassing, or rejecting, or just adapting from both? Last week, Australia had to grapple with just that after the High Court, in a historic decision, ruled that a person called Norrie May-Welby could register as “nonspecific” on official certificates. Now 52, Norrie was identified, physically, as male when she was born, in Scotland, but was drawn to the world of girls, playing with dolls at age 4 and tying her school tie around her head at night to create the illusion of long hair. She escaped into the library monitors’ group at school and made up adventures where she played six characters, five of whom were female: “I didn’t think there was any problem with this,” she says. “After all, just because I wasn’t really from Krypton, didn’t mean I couldn’t imagine being Supergirl.” © 2014 The New York Times Company
Keyword: Sexual Behavior
Link ID: 19462 - Posted: 04.09.2014
By: Larry Cahill, Ph.D. Early in 2013, the Food and Drug Administration (FDA) ordered the makers of the well-known sleep aid Ambien (zolpidem) to cut their recommended dose in half-but only for women. In essence, the FDA was acknowledging that despite extensive testing prior to the drug's release on the market, millions of women had been overdosing on Ambien for 20 years. On February 9, 2014, CBS's 60 Minutes highlighted this fact-and sex differences in general-by powerfully asking two questions: Why did this happen, and are men and women treated equally in research and medicine?1 The answer to the first question is that the biomedical community has long operated on what is increasingly being viewed as a false assumption: that biological sex matters little, if at all, in most areas of medicine. The answer to the second question is no, today's biomedical research establishment is not treating men and women equally. What are some of the key reasons for the biomedical community's false assumption, and why is this situation now finally changing? What are some of the seemingly endless controversies about sex differences in the brain generated by "anti-sex difference" investigators? And what lies at the root of the resistance to sex differences research in the human brain? For a long time, for most aspects of brain function, sex influences hardly mattered to the neuroscience mainstream. The only sex differences that concerned most neuroscientists involved brain regions (primarily a deep-brain structure called the hypothalamus) that regulate both sex hormones and sexual behaviors.2 Neuroscientists almost completely ignored possible sex influences on other areas of the brain, assuming that the sexes shared anything that was fundamental when it came to brain function. Conversely, the neuroscience mainstream viewed any apparent sex differences in the brain as not fundamental- something to be understood after they grasped the fundamental facts. By this logic, it was not a problem to study males almost exclusively, since doing so supposedly allowed researchers to understand all that was fundamental in females without having to consider the complicating aspects of female hormones. To this day, neuroscientists overwhelmingly study only male animals.3 © 2014 The Dana Foundation
Keyword: Sexual Behavior
Link ID: 19461 - Posted: 04.09.2014
By Paul D. Thacker When the FDA denied Sprout Pharmaceutical’s bid last October to begin marketing flibanserin, a drug aimed at treating low sexual desire in women, women’s groups responded in anger. In January, representatives from eight different women’s groups, including the National Organization of Women, met with Janet Woodcock, the FDA’s head of pharmaceuticals, to protest the decision. Congress also got in on the act, with Reps. Debbie Wasserman Schultz, Chellie Pingree, Nita Lowey, and Louise Slaughter sending a letter to FDA Commissioner Margaret Hamburg to implore that, when evaluating drugs for female dysfunction (in medical terms Hypoactive Sexual Desire Disorder, or HSDD), Dr. Hamburg apply "the same standards of consideration given to the approved drugs for men in your risk/benefit evaluation." “We’ve now got 24 drugs for men for either testosterone replacement or erectile dysfunction,” Cindy Whitehead, Sprout’s chief operating officer told the Associated Press. “Yet there are zero drugs for the most common form of sexual dysfunction in women.” Anita H. Clayton, the interim chair of the department of psychiatry and neurobehavioral sciences at the University of Virginia School of Medicine, was more explicit, writing in a blistering column for the Huffington Post: “For the millions of women with HSDD, the FDA must overcome the problem of institutionalized sexism—unconscious and perhaps unintended, but damaging nonetheless.” The chorus was loud and clear: The FDA is sexist. The federal agency charged with approving drugs to protect and improve our health is now standing in the way of a woman’s right to have a satisfying sex life. This framing played out in numerous stories, with similar charges appearing in the American Prospect (“the FDA’s kinda sexist”), and the Washington Post (“Some critics say the agency—consciously or not—may be succumbing to society’s squeamishness about women’s sexual desires compared with those of men”). Not to be outdone with mere institutional sexism, a writer for the Wire mused whether “blatant, medieval sexism is also at play.” © 2014 The Slate Group LLC.
Keyword: Sexual Behavior
Link ID: 19458 - Posted: 04.08.2014
By Karen Kaplan There are lies, damn lies – and the lies that we tell for the sake of others when we are under the influence of oxytocin. Researchers found that after a squirt of the so-called love hormone, volunteers lied more readily about their results in a game in order to benefit their team. Compared with control subjects who were given a placebo, those on oxytocin told more extreme lies and told them with less hesitation, according to a study published Monday in Proceedings of the National Academy of Sciences. Oxytocin is a brain hormone that is probably best known for its role in helping mothers bond with their newborns. In recent years, scientists have been examining its role in monogamy and in strengthening trust and empathy in social groups. Sometimes, doing what’s good for the group requires lying. (Think of parents who fake their addresses to get their kids into a better school.) A pair of researchers from Ben-Gurion University of the Negev in Israel and the University of Amsterdam figured that oxytocin would play a role in this type of behavior, so they set up a series of experiments to test their hypothesis. The researchers designed a simple computer game that asked players to predict whether a virtual coin toss would wind up heads or tails. After seeing the outcome on a computer screen, players were asked to report whether their prediction was correct or not. In some cases, making the right prediction would earn a player’s team a small payment (the equivalent of about 40 cents). In other cases, a correct prediction would cost the team the same amount, and sometimes there was no payoff or cost. Los Angeles Times Copyright 2014
By SINDYA N. BHANOO Monogamy is rare in animals. Even among species that pair off, there is often philandering. But a new genetic analysis adds to the evidence that the South American primates called Azara’s owl monkeys are remarkably faithful to their partners. The study confirms what one of its authors, Eduardo Fernandez-Duque, an evolutionary anthropologist at the University of Pennsylvania who leads the Owl Monkey Project, had long suspected. For 18 years, he and other Penn researchers have been observing the Azara’s owl monkey in the Chaco region of Argentina. Not only have they never witnessed a philanderer, but they have also found that infant owl monkeys get an unusual amount of care from their fathers. “The male plays with the infant and the male shares food with the infant even more than the mother,” Dr. Fernandez-Duque said. “The males care because these are their offspring, and this has a direct benefit in terms of reproductive success.” In the new study, published in the Proceedings of the Royal Society B, the researchers performed genetic analysis on 35 offspring born to 17 owl monkey pairs and confirmed that the parents were monogamous for the mating season. The monkey is the first primate and only the fifth mammal for which monogamy has been verified through genetics. Because paternal care is also seen in other species of owl monkeys, the scientists suspect that they, too, are serially monogamous. © 2014 The New York Times Company
by Clare Wilson It's a vicious circle of the cruellest kind. Stress might be causing infertility in women, according to new research. This could explain some cases in which couples are diagnosed as infertile with no apparent cause. Taking longer than usual to conceive can lead to stress, so the problem could become self-perpetuating. A link between everyday life stresses and infertility has long been suspected, but there has been little hard evidence connecting the two. Women receiving fertility treatment are generally advised to avoid stress, but not so the average person trying to conceive. An estimated one in seven couples in the UK have fertility problems and, in about a quarter of those, there is no known medical explanation, and they are given a diagnosis of "unexplained infertility". To explore the role of stress, Courtney Lynch at Ohio State University in Columbus and her colleagues collected saliva samples from 373 women in the US who had just started trying to conceive naturally and measured levels of an enzyme called alpha-amylase, a marker of stress. After one year of regular unprotected sex, about 13 per cent of the couples had failed to get pregnant, the standard definition of infertility. The third of women who had the highest alpha-amylase levels were twice as likely to be in the infertile group as the third with the lowest levels. In a previous study, Lynch's team found that those with higher levels of the stress enzyme were slightly less likely to conceive in their first month of trying. But this is the first time that alpha-amylase has been linked to clinical infertility. © Copyright Reed Business Information Ltd.